Abstract

The article presents innovative methods of diagnosis and treatment in women with infertility on the background of uterine fibroids.Target: To assess the role of uterine fibroids immunocorrection factors in the formation of clinical variants of uterine fibroids to develop innovative methods of diagnosis and treatment in women with infertility against the background of reasonable differentiated corrective therapy.Materials and Methods: Survey 2018-2022 was conducted. in the Bukhara region, 175 questionnaires of women with infectious and inflammatory diseases of the pelvic organs were analyzed. Of these, 140 (52.6%) had uterine fibroids of various shapes and locations. Of these, single uterine fibroids occurred in 32% of cases, and 68% - multiple uterine fibroids. We examined 85 women with clinical manifestations of uterine fibroids. 47 women with symptomatic uterine fibroids and infertility and 38 with asymptomatic uterine fibroids and infertility.Results: The results of the study showed that the complex treatment of women with symptomatic uterine fibroids and uterine fibroids with the immunocorrective drug T-life after hormone therapy showed high efficiency, reproductive function was restored in 64.3% of women, which without immunocorrection uterine myoma was 48.1%. in women with asymptomatic uterine fibroids after hormone therapy, the inclusion of the drug Likopid had a positive clinical and immunocorrection effect on uterine myoma, reproductive function was restored in 60.0% of women, which was 44.4% without uterine myoma correction.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call